Table 5.
Association of HPV16 E7 gene mutations with clinicopathological features of cervical cancer.
| E7 mutations | E7 unmutated | P value | |
|---|---|---|---|
| Total n | 24 | 5 | |
| FIGO stage n (%) | |||
| I | 19 (79.2) | 4 (80.0) | .42 |
| II | 1 (4.2) | 1 (20.0) | |
| III | 4 (16.7) | 0 (0.0) | |
| Pathological type n (%) | |||
| Squamous carcinoma | 20 (83.3) | 4 (80.0) | .37 |
| Adenocarcinoma | 3 (12.5) | 0 (0.0) | |
| Adenosquamous carcinoma | 1 (4.2) | 1 (20.0) | |
| Vascular metastasis n (%) | |||
| + | 13 (54.2) | 1 (20.0) | .44 |
| − | 10 (41.7) | 4 (80.0) | |
| Unknown | 1 (4.2) | 0 (0.0) | |
| Lymph node metastasis n (%) | |||
| + | 7 (29.2) | 0 (0.0) | .41 |
| − | 16 (66.7) | 5 (100.0) | |
| Unknown | 1 (4.2) | 0 (0.0) |
FIGO = International Federation of Gynecology and Obstetrics.